294 related articles for article (PubMed ID: 20426566)
1. FDA's new regulatory paradigms for in vitro diagnostic devices.
Robinowitz M; Gutman SI
Cytotherapy; 1999; 1(4):353-7. PubMed ID: 20426566
[No Abstract] [Full Text] [Related]
2. FDA's proposed regulatory approach to regulation of hematopoietic stem/progenitor cell products.
Harvath L
Cytotherapy; 1999; 1(4):358-9. PubMed ID: 20440912
[No Abstract] [Full Text] [Related]
3. FDA flexes muscle in oversight of medical devices, technologies.
Cruise C
Biomed Instrum Technol; 2011; 45(2):105-8. PubMed ID: 21466325
[No Abstract] [Full Text] [Related]
4. FDA medical device approval: things you didn't learn in medical school or residency.
Buch B
Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):407-12. PubMed ID: 17849025
[TBL] [Abstract][Full Text] [Related]
5. Pharmaceuticals and medical devices: medical devices.
Berry MD
Issue Brief Health Policy Track Serv; 2013 Dec; ():1-49. PubMed ID: 24482892
[No Abstract] [Full Text] [Related]
6. Pharmaceuticals and medical devices: medical devices. Issue brief.
Berry MD
Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
[No Abstract] [Full Text] [Related]
7. Design controls.
Bartoo G
IEEE Eng Med Biol Mag; 2003; 22(2):112-4. PubMed ID: 12733469
[No Abstract] [Full Text] [Related]
8. The FDA's humanitarian device exemption program.
Eydelman MB; Chen EA
Health Aff (Millwood); 2011 Jun; 30(6):1210-2; author reply 1212. PubMed ID: 21653975
[No Abstract] [Full Text] [Related]
9. The Center for Devices and Radiological health: an update.
Donawa M
Med Device Technol; 2001 Dec; 12(10):24, 26-7. PubMed ID: 15966141
[TBL] [Abstract][Full Text] [Related]
10. Pharmaceuticals and Medical Devices: FDA Oversight.
White RS;
Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-33. PubMed ID: 29361662
[No Abstract] [Full Text] [Related]
11. Pharmaceuticals and Medical Devices: Medical Devices.
Berry MD;
Issue Brief Health Policy Track Serv; 2015 Dec; ():1-64. PubMed ID: 27116798
[No Abstract] [Full Text] [Related]
12. The critical path to new medical devices.
Ashar B; Barnett M; Schultz D
Biomed Instrum Technol; 2005; 39(4):304-6. PubMed ID: 16111410
[No Abstract] [Full Text] [Related]
13. FDA's device inspection lacking. Two reports point to technology, staffing as key culprits.
Rhea S
Mod Healthc; 2008 Feb; 38(5):10-1. PubMed ID: 18318369
[No Abstract] [Full Text] [Related]
14. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
Basile EM; Tolomeo D; Gluck E
Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
[TBL] [Abstract][Full Text] [Related]
15. Regulatory reticence and medical devices.
Fox DM; Zuckerman DM
Milbank Q; 2014 Mar; 92(1):151-9. PubMed ID: 24597559
[No Abstract] [Full Text] [Related]
16. The FDA's role in medical device clinical studies of human subjects.
Saviola J
J Neural Eng; 2005 Mar; 2(1):S1-4. PubMed ID: 15876645
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceuticals and medical devices: medical devices. Year end issue brief.
Tiffany S
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-19. PubMed ID: 18345548
[No Abstract] [Full Text] [Related]
18. US manufacturing guideline for IVD products.
Donawa M
Med Device Technol; 2000 Oct; 11(8):23-4. PubMed ID: 11185183
[TBL] [Abstract][Full Text] [Related]
19. Devices and the food and drug administration.
Phillips SJ; Phillips RS
Artif Organs; 2005 May; 29(5):363-5. PubMed ID: 15854210
[No Abstract] [Full Text] [Related]
20. The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?
Fargen KM; Frei D; Fiorella D; McDougall CG; Myers PM; Hirsch JA; Mocco J
J Neurointerv Surg; 2013 Jul; 5(4):269-75. PubMed ID: 22764203
[No Abstract] [Full Text] [Related]
[Next] [New Search]
